Accelerating access to blood disorders care

Haemophilia is an inherited bleeding disorder in which the blood does not clot properly. 80 percent of people with haemophilia live in low- and middle-income countries. Many are undiagnosed and lack access to quality care. Left untreated, people with haemophilia can suffer from pain, disabilities and fatal complications. That is why it is so important to ensure prompt diagnosis, access to care and treatment, and empower patients and to talk about the disease in public with authentic stories.

For the Novo Nordisk Haemophilia Foundation, working together is key to create greater impact.  This is not only true for the operational partners, who work with different stakeholders in their community to ensure that each relevant group has a voice. Partnerships with other organisations are also encouraged to enhance impact through joint initiatives, such as in the joint Kenya-Tanzania project. 

For communications is as true when working with partners such as Fairpicture: “Documenting our partners’ impact on people’s lives and capturing authentic stories inspires us and others to continue impacting care, together. Working with Fairpicture and with visual creators like Amini Suwedi gave us the opportunity to enrich our storytelling with new perspectives and lights.

Year in Review 2021

Annual report highlight Tanzania